UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
Article in Cancer Medicine (August 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Cancer Medicine (August 2023)
Article in Pathology & Oncology Research (January 2023)
Article in Frontiers in Endocrinology (March 2022)